News

Published on 8 Mar 2024 on Insider Monkey via Yahoo Finance

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript


Article preview image

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript March 6, 2024

Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.12, expectations were $-1.58. Inovio Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good afternoon, ladies and gentlemen and welcome to the INOVIO Fourth Quarter and Year-End 2023 Financial Results Conference Call. At this time all lines are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] This call is being recorded on Wednesday, March 06, 2024. I would now like to turn the conference over to Thomas Hong, Manager of Investor Relations. Please go ahead.

NASDAQ.INO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Inovio Pharmaceuticals Inc (INO) Q3 2024 Earnings Call Highlights: Progress in...

Release Date: November 14, 2024 For the complete transcript of the earnings call, please refer to...

GuruFocus.com · via Yahoo Finance 15 Nov 2024

Inovio (INO) Up as Lead Drug Gets Innovative Medicine Tag in UK

Inovio (INO) soars 19% as its lead candidate, INO-3107, receives the innovative medicine tag unde...

Zacks · via Yahoo Finance 28 Jun 2024

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript March 6, 2024 Inovio P...

Insider Monkey via Yahoo Finance 8 Mar 2024

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript November 9, 2023 Inovi...

Insider Monkey via Yahoo Finance 10 Nov 2023

Inovio Pharma (INO) Stock Surges 19% This Month: Here's Why

Inovio Pharma (INO) rises 19% this month after the FDA issues positive feedback on data from a ph...

Zacks · via Yahoo Finance 9 Nov 2023

INOVIA's (INO) Rare Disease Drug Gets EC's Orphan Tag, Stock Up

INOVIA Pharmaceuticals INO announced that European Commission has granted orphan drug designation...

Zacks via Yahoo Finance 24 May 2023

These Analysts Think Inovio Pharmaceuticals, Inc.'s (NASDAQ:INO) Sales Are Under Threat

The analysts covering Inovio Pharmaceuticals, Inc. (NASDAQ:INO) delivered a dose of negativity to...

Simply Wall St. via Yahoo Finance 15 May 2023

Analysts Have Lowered Expectations For Inovio Pharmaceuticals, Inc. (NASDAQ:INO) After Its Latest...

As you might know, Inovio Pharmaceuticals, Inc. (NASDAQ:INO) last week released its latest first-...

Simply Wall St. via Yahoo Finance 13 May 2023

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2022 Earnings Call Transcript

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2022 Earnings Call Transcript March 1, 2023 Operator...

Insider Monkey via Yahoo Finance 6 Mar 2023

Inovio Pharma Releases Favorable Data From Booster DNA Vaccine Candidate For Ebola

Inovio Pharmaceuticals Inc (NASDAQ: INO) announced results from a Phase 1b trial evaluating INO-4...

Benzinga via Yahoo Finance 3 Feb 2023